Physician profile
Song Tan
NPI 1902903685
$1,861.83
in general payments reported to CMS, 2019-2025
10 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $247 · 2021: $229 · 2022: $395 · 2023: $428 · 2024: $264 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $535.48 | 2019-2024 | |
| Glaxosmithkline, LLC. | $465.03 | 2020-2025 | Bexsero |
| Pfizer INC. | $296.25 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $290.40 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Cranial Technologies, INC | $133.43 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $41.39 | 2024 | |
| Seqirus USA INC | $30.91 | 2025 | Flucelvax |
| Astrazeneca Pharmaceuticals LP | $23.43 | 2023 | Flumist Quadrivalent |
| Ultragenyx Pharmaceutical INC. | $23.04 | 2021 | |
| Hologic Sales and Service, LLC | $22.47 | 2023 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Song Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.